The groundbreaking approach of the medication represents a exciting development in the handling of the condition. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide783874.ltfblog.com/40410276/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment